Holen Sie sich die Stockscreener-App
0.631
7.59%
-0.0518
Schlusskurs vom Vortag:
$0.6828
Offen:
$0.69
24-Stunden-Volumen:
115.55K
Relative Volume:
0.59
Marktkapitalisierung:
$28.23M
Einnahmen:
$80.28M
Nettoeinkommen (Verlust:
$-38.83M
KGV:
-0.7586
EPS:
-0.8318
Netto-Cashflow:
$-28.67M
1W Leistung:
+12.62%
1M Leistung:
-18.91%
6M Leistung:
-57.36%
1J Leistung:
-34.01%
1-Tages-Spanne:
$0.63
$0.69
1-Wochen-Bereich:
$0.5681
$0.7499
52-Wochen-Spanne:
$0.5011
$2.20
Tela Bio Inc Stock (TELA) Company Profile
Firmenname
Tela Bio Inc
Sektor
Branche
Telefon
484-320-2930
Adresse
1 GREAT VALLEY PARKWAY, SUITE 24, MALVERN, PA
Compare TELA vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TELA
Tela Bio Inc
|
0.631 | 30.55M | 80.28M | -38.83M | -28.67M | -0.8318 |
ABT
Abbott Laboratories
|
96.00 | 168.22B | 45.13B | 6.28B | 7.40B | 3.5895 |
SYK
Stryker Corp
|
338.34 | 131.49B | 25.12B | 3.25B | 4.28B | 8.3984 |
MDT
Medtronic Plc
|
85.00 | 110.66B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
60.99 | 95.46B | 20.08B | 2.89B | 3.66B | 1.9391 |
EW
Edwards Lifesciences Corp
|
81.44 | 46.69B | 6.07B | 1.06B | 1.34B | 1.8063 |
Tela Bio Inc Stock (TELA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-21 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2022-05-31 | Eingeleitet | Lake Street | Buy |
| 2019-12-03 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-12-03 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2019-12-03 | Eingeleitet | Jefferies | Buy |
| 2019-12-03 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Tela Bio Inc Aktie (TELA) Neueste Nachrichten
TELA Bio launches OviTex Long-Term Resorbable with PLGA reinforcement to advance robotic surgery platforms - Traders Union
TELA Bio urges case-specific approaches for hernia repair at Intuitive Connect - Traders Union
TELA Bio (TELA) price target decreased by 34.78% to 2.30 - MSN
Volume Report: What analysts say about TELA Bio Inc stock2026 Spike Watch & Reliable Breakout Forecasts - baoquankhu1.vn
Aug Levels: What analysts say about TELA Bio Inc stock2026 Key Highlights & Daily Market Momentum Tracking - baoquankhu1.vn
Market Wrap: Will TELA Bio Inc benefit from AI trendsM&A Rumor & Daily Technical Stock Forecast Reports - baoquankhu1.vn
Stock Report: Is TELA Bio Inc attractive at current valuation2026 Spike Watch & Stepwise Swing Trade Plans - baoquankhu1.vn
Investment Analysts’ Weekly Ratings Updates for TELA Bio (TELA) - Defense World
TELA Stock Price, Quote & Chart | TELA BIO INC (NASDAQ:TELA) - ChartMill
TELA Bio unveils new hernia solution with focus on simplicity and reliability - Traders Union
Aug Fed Impact: Is TELA Bio Inc a stock for growth or value investors2026 AllTime Highs & Safe Entry Trade Signal Reports - baoquankhu1.vn
Q3 2025 TELA Bio Inc Earnings Call Transcript - GuruFocus
Citizens Jmp Issues Pessimistic Forecast for TELA Bio (NASDAQ:TELA) Stock Price - Defense World
Published on: 2026-03-28 00:22:27 - baoquankhu1.vn
TELA Bio, Inc.Common stock - FinancialContent
TELA Bio analysts cut their forecasts after Q4 results - msn.com
TELA Bio, Inc. (NASDAQ:TELA) Q4 2025 earnings call transcript - MSN
Citizens cuts Tela Bio stock price target on commercial transition By Investing.com - Investing.com South Africa
Citizens cuts Tela Bio stock price target on commercial transition - Investing.com UK
Tela Bio targets at least 8% revenue growth in 2026 while advancing commercial transformation - MSN
Canaccord Genuity Group Lowers TELA Bio (NASDAQ:TELA) Price Target to $2.00 - Defense World
TELA Bio, Inc. (TELA) reports Q4 loss, lags revenue estimates - MSN
Analysts Offer Insights on Healthcare Companies: Ultragenyx Pharmaceutical (RARE), TELA Bio (TELA) and Nuvalent (NUVL) - The Globe and Mail
EPS Watch: What analysts say about TELA Bio Inc stock2026 Volatility Report & Consistent Income Trade Ideas - baoquankhu1.vn
TELA Bio (NASDAQ:TELA) Given New $1.00 Price Target at Piper Sandler - Defense World
TELA Bio (NASDAQ:TELA) Given New $2.00 Price Target at Lake Street Capital - Defense World
Piper Sandler cuts TELA Bio stock price target on lowered outlook - Investing.com Australia
TELA Bio Analysts Cut Their Forecasts After Q4 Results - benzinga.com
Patterns Watch: Is TELA Bio Inc showing insider buyingWeekly Profit Analysis & Consistent Profit Trade Alerts - baoquankhu1.vn
TELA Bio 10-K: Revenue $80.3M, Net Loss $38.8M - TradingView
TELA Bio (NASDAQ: TELA) grows 2025 revenue 16% while investing heavily in R&D - Stock Titan
Piper Sandler Lowers Price Target for TELA Bio (TELA) to $1.00 | - GuruFocus
TELA Bio net loss hits USD 9M in Q4 2025 - Medical Buyer
TELA Bio (TELA) Rating Maintained but Price Target Lowered by An - GuruFocus
Analyst Maintains 'Buy' Rating for TELA, Lowers Price Target to $2.00 | TELA Stock News - GuruFocus
Jefferies cuts TELA Bio stock price target on slower growth outlook - Investing.com UK
TELA Bio (TELA) Q4 2025 Earnings Call Transcript - AOL.com
TELA Bio, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
TELA Bio, Inc. (NASDAQ:TELA) Q4 2025 Earnings Call Transcript - insidermonkey.com
Jefferies cuts TELA Bio stock price target on slower growth outlook By Investing.com - Investing.com South Africa
TELA Bio | 10-K: FY2025 Annual Report - Moomoo
TELA Bio Inc (TELA) Q4 2025 Earnings Call Highlights: Record Revenue Growth Amid Strategic ... By GuruFocus - Investing.com Canada
TELA Bio Inc (TELA) Q4 2025 Earnings Call Highlights: Record Rev - GuruFocus
Tela Bio Earnings Call: Growth Momentum, Cautious Outlook - tipranks.com
TELA Bio, Inc. (TELA) Announces Fourth Quarter Loss, Falls Short of Revenue Expectations - Bitget
Earnings call transcript: TELA Bio Q4 2025 surprises with EPS beat but revenue miss - Investing.com
TelaBio (TELA) Reports Record Quarterly Revenue in Q4 - GuruFocus
TELA Bio Inc reports results for the quarter ended December 31Earnings Summary - TradingView
TELA Bio Q4 Net Loss Narrows, Revenue Rises - marketscreener.com
TELA Bio, Inc. (TELA) Reports Q4 Loss, Lags Revenue Estimates - Yahoo Finance
TELA Bio Inc (NASDAQ:TELA) Reports Record Q4 Revenue but Misses Sales Estimates - chartmill.com
Finanzdaten der Tela Bio Inc-Aktie (TELA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.74%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):